Lista de obras - Florian R. Schroeck - Dominio Público Uruguay

Adherence to performance measures and outcomes among men treated for prostate cancer

artículo científico publicado en 2014

Are repeat prostate biopsies safe? A cohort analysis from the SEARCH database

artículo científico publicado en 2012

Assembling and validating data from multiple sources to study care for Veterans with bladder cancer

artículo científico publicado en 2017

Certificate of need legislation and the dissemination of robotic surgery for prostate cancer

artículo científico publicado en 2012

Certificate of need regulations and the diffusion of intensity-modulated radiotherapy

artículo científico publicado en 2012

Comparison of prostate-specific antigen recurrence-free survival in a contemporary cohort of patients undergoing either radical retropubic or robot-assisted laparoscopic radical prostatectomy

artículo científico publicado en 2008

Cyclo19,31[D-Cys19]-uPA19-31 is a potent competitive antagonist of the interaction of urokinase-type plasminogen activator with its receptor (CD87)

scientific article published on 01 August 2001

Defining potency: a comparison of the International Index of Erectile Function short version and the Expanded Prostate Cancer Index Composite.

artículo científico publicado en 2008

Development of a Natural Language Processing Engine to Generate Bladder Cancer Pathology Data for Health Services Research

artículo científico publicado en 2017

Differential adoption of laser prostatectomy for treatment of benign prostatic hyperplasia

artículo científico publicado en 2013

Do nomograms predict aggressive recurrence after radical prostatectomy more accurately than biochemical recurrence alone?

artículo científico publicado en 2008

Early Stage Bladder Cancer: Do Pathology Reports Tell Us What We Need to Know?

artículo científico publicado en 2016

Editorial Comment

Editorial comment

artículo científico publicado en 2013

Editorial comment

Factors predicting early and late phase decline of sexual health-related quality of life following radical prostatectomy

artículo científico publicado en 2011

Factors predicting prostatic biopsy Gleason sum under grading

artículo científico publicado en 2009

Geographic Variation in Cystoscopy Rates for Suspected Bladder Cancer between Female and Male Medicare Beneficiaries

scientific article published on 20 August 2018

Health Care Integration and Quality among Men with Prostate Cancer

artículo científico publicado en 2016

Impact of Accountable Care Organizations on Diagnostic Testing for Prostate Cancer

artículo científico publicado en 2018

Interaction of plasminogen activator inhibitor type-1 (PAI-1) with vitronectin

artículo científico publicado en 2002

Interaction of plasminogen activator inhibitor type-1 (PAI-1) with vitronectin (Vn): mapping the binding sites on PAI-1 and Vn.

artículo científico publicado en 2002

Introduction of laser technology and procedure use for benign prostatic hyperplasia: data from Florida.

artículo científico publicado en 2012

Managed care and the diffusion of intensity-modulated radiotherapy for prostate cancer

artículo científico publicado en 2012

Managed care and the dissemination of robotic prostatectomy

artículo científico publicado en 2014

MicroRNA Dysregulation and Non-Muscle-Invasive Bladder Cancer Prognosis

scientific article published on 30 January 2019

Non-muscle alpha-actinin-4 interacts with plasminogen activator inhibitor type-1 (PAI-1).

artículo científico publicado en 2004

Patient selection for hemiablative focal therapy of prostate cancer: variables predictive of tumor unilaterality based upon radical prostatectomy

artículo científico publicado en 2009

Pneumoscrotum With Extensive Penile and Abdominal Subcutaneous Emphysema: A Case Report of Uncertain Etiology

artículo científico publicado en 2017

Population based trends in the surgical treatment of benign prostatic hyperplasia

artículo científico publicado en 2012

Pretreatment expectations of patients undergoing robotic assisted laparoscopic or open retropubic radical prostatectomy

artículo científico publicado en 2012

Prostate cancer: the new landscape

artículo científico publicado en 2009

Race and prostate weight as independent predictors for biochemical recurrence after radical prostatectomy

artículo científico publicado en 2008

Re-calibration and external validation of an existing nomogram to predict aggressive recurrences after radical prostatectomy

artículo científico publicado en 2009

Receipt of best care according to current quality of care measures and outcomes in men with prostate cancer.

artículo científico publicado en 2014

Regional variation in quality of prostate cancer care

scientific article published on 19 October 2013

Reply by the authors

Robot-assisted laparoscopic prostatectomy is not associated with early postoperative radiation therapy

artículo científico publicado en 2009

Satisfaction and regret after open retropubic or robot-assisted laparoscopic radical prostatectomy

artículo científico publicado en 2008

Technology diffusion and prostate cancer quality of care.

artículo científico publicado en 2014

Testing for the recurrent HOXB13 G84E germline mutation in men with clinical indications for prostate biopsy

artículo científico publicado en 2012

The Burden of Cystoscopic Bladder Cancer Surveillance: Anxiety, Discomfort, and Patient Preferences for Decision Making

artículo científico publicado en 2017

The Shared Equal Access Regional Cancer Hospital (SEARCH) nomogram for risk stratification in intermediate risk group of men with prostate cancer: validation in the Duke Prostate Center database

scientific article published on 25 August 2009

The impact of frequent cystoscopy on surgical care and cancer outcomes among patients with low-risk, non-muscle-invasive bladder cancer

article

The impact of technology diffusion on treatment for prostate cancer

artículo científico publicado en 2013

Trainees do not negatively impact the institutional learning curve for robotic prostatectomy as characterized by operative time, estimated blood loss, and positive surgical margin rate

artículo científico publicado en 2008

Understanding hospital readmission intensity after radical cystectomy

artículo científico publicado en 2014

Understanding variation in the quality of the surgical treatment of prostate cancer.

artículo científico

Use of advanced treatment technologies among men at low risk of dying from prostate cancer.

artículo científico publicado en 2013

Variation in use of active surveillance among men undergoing expectant treatment for early stage prostate cancer.

artículo científico publicado en 2014

Lista de obras de Florian R. Schroeck

Adherence to performance measures and outcomes among men treated for prostate cancer

Are repeat prostate biopsies safe? A cohort analysis from the SEARCH database

Assembling and validating data from multiple sources to study care for Veterans with bladder cancer

Certificate of need legislation and the dissemination of robotic surgery for prostate cancer

Certificate of need regulations and the diffusion of intensity-modulated radiotherapy

Comparison of prostate-specific antigen recurrence-free survival in a contemporary cohort of patients undergoing either radical retropubic or robot-assisted laparoscopic radical prostatectomy

Cyclo19,31[D-Cys19]-uPA19-31 is a potent competitive antagonist of the interaction of urokinase-type plasminogen activator with its receptor (CD87)

Defining potency: a comparison of the International Index of Erectile Function short version and the Expanded Prostate Cancer Index Composite.

Development of a Natural Language Processing Engine to Generate Bladder Cancer Pathology Data for Health Services Research

Differential adoption of laser prostatectomy for treatment of benign prostatic hyperplasia

Do nomograms predict aggressive recurrence after radical prostatectomy more accurately than biochemical recurrence alone?

Early Stage Bladder Cancer: Do Pathology Reports Tell Us What We Need to Know?

Editorial Comment

Editorial comment

Editorial comment

Factors predicting early and late phase decline of sexual health-related quality of life following radical prostatectomy

Factors predicting prostatic biopsy Gleason sum under grading

Geographic Variation in Cystoscopy Rates for Suspected Bladder Cancer between Female and Male Medicare Beneficiaries

Health Care Integration and Quality among Men with Prostate Cancer

Impact of Accountable Care Organizations on Diagnostic Testing for Prostate Cancer

Interaction of plasminogen activator inhibitor type-1 (PAI-1) with vitronectin

Interaction of plasminogen activator inhibitor type-1 (PAI-1) with vitronectin (Vn): mapping the binding sites on PAI-1 and Vn.

Introduction of laser technology and procedure use for benign prostatic hyperplasia: data from Florida.

Managed care and the diffusion of intensity-modulated radiotherapy for prostate cancer

Managed care and the dissemination of robotic prostatectomy

MicroRNA Dysregulation and Non-Muscle-Invasive Bladder Cancer Prognosis

Non-muscle alpha-actinin-4 interacts with plasminogen activator inhibitor type-1 (PAI-1).

Patient selection for hemiablative focal therapy of prostate cancer: variables predictive of tumor unilaterality based upon radical prostatectomy

Pneumoscrotum With Extensive Penile and Abdominal Subcutaneous Emphysema: A Case Report of Uncertain Etiology

Population based trends in the surgical treatment of benign prostatic hyperplasia

Pretreatment expectations of patients undergoing robotic assisted laparoscopic or open retropubic radical prostatectomy

Prostate cancer: the new landscape

Race and prostate weight as independent predictors for biochemical recurrence after radical prostatectomy

Re-calibration and external validation of an existing nomogram to predict aggressive recurrences after radical prostatectomy

Receipt of best care according to current quality of care measures and outcomes in men with prostate cancer.

Regional variation in quality of prostate cancer care

Reply by the authors

Robot-assisted laparoscopic prostatectomy is not associated with early postoperative radiation therapy

Satisfaction and regret after open retropubic or robot-assisted laparoscopic radical prostatectomy

Technology diffusion and prostate cancer quality of care.

Testing for the recurrent HOXB13 G84E germline mutation in men with clinical indications for prostate biopsy

The Burden of Cystoscopic Bladder Cancer Surveillance: Anxiety, Discomfort, and Patient Preferences for Decision Making

The Shared Equal Access Regional Cancer Hospital (SEARCH) nomogram for risk stratification in intermediate risk group of men with prostate cancer: validation in the Duke Prostate Center database

The impact of frequent cystoscopy on surgical care and cancer outcomes among patients with low-risk, non-muscle-invasive bladder cancer

The impact of technology diffusion on treatment for prostate cancer

Trainees do not negatively impact the institutional learning curve for robotic prostatectomy as characterized by operative time, estimated blood loss, and positive surgical margin rate

Understanding hospital readmission intensity after radical cystectomy

Understanding variation in the quality of the surgical treatment of prostate cancer.

Use of advanced treatment technologies among men at low risk of dying from prostate cancer.

Variation in use of active surveillance among men undergoing expectant treatment for early stage prostate cancer.